City of Hope

Long Beach, CA

Sorting 3 by

Accepting patients

TRIlogy-3

A Phase 2, Open-label Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) Who Have Received at Least 3 Prior Lines of Therapy Including a PI, an IMiD, and an Anti-CD38 Antibody
Learn more
  • Trispecific Antibody
  • GPRC5D
  • BCMA
  • Phase 2

Not yet accepting

Impact of Cancer-Directed Treatment

A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Learn more
  • Observational Trial

Accepting patients

Leflunomide

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Learn more
  • Disease-Modifying Antirheumatic Drug
  • Phase 2
1 hidden based on your filters.Show All